hsa-mir-1228: hsa-mir-1228 is a microRNA that has been used as an internal control in various studies [PMC7221502]. It has been used in combination with spike-in control cel-miR-39 and as an endogenous normalizer [PMC9778022]. hsa-mir-1228 has been associated with lung cancer [PMC9293659]. In a study comparing kidney tissues of healthy individuals and patients with DN, hsa-mir-1228 was found to be differentially expressed [PMC8616647]. It has also been reported to prevent cellular apoptosis by targeting the 3'UTR of MOAP1 mRNA [PMC8744590]. hsa-mir-1228 has been identified as a potential endogenous reference gene for circulating miRNAs in cancer patients [PMC7112021]. It was selected as a reference gene based on its stability assessed through different algorithms [PMC7112021]. Furthermore, hsa-mir-1228 has been found to be differentially expressed in breast cancer compared to normal tissues [PMC8004706]. It has also been identified as a hub miRNA within the miRNA network associated with good prognosis in breast cancer patients [PMC8004706]. Overall, hsa-mir-1228 is a microRNA that plays various roles and can be used as an internal control or reference gene in different studies.